Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

Share Price is delayed by 15 minutes
Get Live Data
1.70    -0.05 (-2.86%)
Bid:
1.69
Ask:
1.70
Spread: 0.01 (0.592%)
Market Cap: €511.08m
GWI Live PriceLast checked at - London Stock Exchange

Intraday Globalworth Share Chart

Scrip Dividend Share Reference Price

27 Mar 2025 07:00

RNS Number : 3930C
Globalworth Real Estate Inv Ltd
27 March 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION.

FOR IMMEDIATE RELEASE

27 March 2025

Globalworth Real Estate Investments Limited

("Globalworth" or the "Company")

Scrip Dividend Share Reference Price

 

Further to the Company's announcement on 11 March 2025 and as further described in the scrip dividend circular published by the Company on the same date (the "Scrip Dividend Circular"), the Company has approved the payment of an interim dividend in respect of the six month period ended 31 December 2024 of 9 cents per ordinary share (the "Interim Dividend") and shareholders may elect to receive a scrip dividend alternative to the Interim Dividend (the "Scrip Dividend Alternative") so that Qualifying Shareholders receive new ordinary shares in the Company (the "Scrip Dividend Shares") instead of cash in respect of all or part of their entitlement to the Interim Dividend calculated on the basis of the Reference Price.

 

The Reference Price is 208 cents per Scrip Dividend Share. The Reference Price has been determined by the Company on the basis of a discount of 20% to the average of the middle market quotations for the Company's shares as derived from the Daily Official List (or any other publication of a recognised investment exchange showing quotations for the Company's shares) on the five consecutive dealing days from and including the Ex-Dividend Date.

 

The final date and time for Qualifying Shareholders to elect to receive the Scrip Dividend Alternative is 5.00 p.m. on 4 April 2025. The process for electing to receive the Scrip Dividend Alternative is set out in the Scrip Dividend Circular, which is available on the Company's website at https://www.globalworth.com/investor-relations/corporate-documents/.

 

All capitalised terms used in this announcement shall, unless otherwise defined, have the meanings given to them in the Scrip Dividend Circular.

 

For further information visit www.globalworth.com or contact:

Enquiries 

Rashid Mukhtar

Group CFO

 

Tel: +40 732 800 000

Panmure Liberum (Nominated Adviser and Broker)

Atholl Tweedie 

Tel: +44 20 7886 2500

 

About Globalworth / Note to Editors: 

Globalworth is a listed real estate company active in Central and Eastern Europe, quoted on the AIM-segment of the London Stock Exchange. It has become the pre-eminent office investor in the CEE real estate market through its market-leading positions both in Poland and Romania. Globalworth acquires, develops and directly manages high-quality office properties in prime locations, generating rental income from reputed tenants from around the globe. Managed by over 250 professionals across Cyprus, Guernsey, Poland and Romania the combined value of its portfolio is €2.6 billion, as at 31 December 2024. Approximately 98.5% of the portfolio is in income-producing assets, predominately in the office sector, and leased to a diversified array of over 650 national and multinational corporates. In Poland Globalworth is present in Warsaw, Wroclaw, Lodz, Krakow, Gdansk and Katowice, while in Romania its assets span Bucharest, Constanta and Craiova.

For more information, please visit www.globalworth.com and follow us on Facebook, Instagram and LinkedIn.

Excluded Territories

 

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable legal or regulatory requirements. In particular, the ability of persons who are not resident in the United Kingdom or who are subject to the laws of another jurisdiction to elect to receive the Scrip Dividend Alternative may be affected by the laws of the relevant jurisdictions in which they are located or to which they are subject. Any failure to comply with applicable legal or regulatory requirements of any jurisdiction may constitute a violation of securities laws in that jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBCGDXDUDDGUL
Date   Source Headline
3rd Jun 20263:11 pmRNSFitch investment grade credit rating maintained
22nd May 202611:39 amRNSSatisfaction of employee share awards and TVR
15th May 20267:00 amRNSNotice of AGM and Availability of Annual Report
24th Apr 20265:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
31st Mar 20267:00 amRNSAudited Results FY25, Annual Report, Notice of AGM
26th Mar 20261:00 pmRNSS&P - 'BB' Rating affirmed
19th Mar 20267:00 amRNSScrip Dividend Share Reference Price
27th Feb 20267:01 amRNSInterim Dividend & Scrip Alternative
27th Feb 20267:00 amRNSCondensed Unaudited Results for FY 31 Dec 2025
26th Jan 20261:00 pmRNSPartial Bond Redemption
6th Nov 202511:04 amRNSAppointment of Joint CEOs
23rd Sep 20257:00 amRNSHalf-year Report
28th Aug 20257:01 amRNSInterim Dividend Payment
28th Aug 20257:00 amRNSNotice of Interim Results & Prelim Interim Results
26th Jun 20251:41 pmRNSFitch investment grade credit rating maintained
23rd Jun 202512:42 pmRNSResult of AGM
23rd May 202511:45 amRNSBuy back of Shares into Treasury and TVR
15th May 20257:00 amRNSNotice of AGM
1st May 202511:30 amRNSSatisfaction of employee share awards and TVR
25th Apr 20255:35 pmRNSPulbication of Green Allocations Report
23rd Apr 202512:16 pmRNSExtension of secured bank financing
8th Apr 20253:18 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
27th Mar 20257:00 amRNSScrip Dividend Share Reference Price
25th Mar 20257:00 amRNSPublication of Annual Report and Date of AGM
21st Mar 20253:01 pmRNSS&P - revisions to credit rating and outlook
11th Mar 202511:13 amRNSInterim Dividend & Scrip Alternative
11th Mar 20257:00 amRNSCondensed Unaudited Results for FY 31 Dec 2024
18th Oct 20248:01 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSIssue of Scrip Dividend Shares & Admission to AIM
24th Sep 20247:00 amRNSHalf-year Report
19th Sep 20247:00 amRNSScrip Dividend Share Reference Price
16th Sep 20243:54 pmRNSHolding(s) in Company
30th Aug 20247:01 amRNSInterim Dividend & Scrip Alternative
30th Aug 20247:00 amRNSNotice of Interim Results & Prelim Interim Results
6th Aug 20244:10 pmRNSChange of Registered Office
18th Jul 20244:35 pmRNSResults of Tender Offers
11th Jul 20248:15 amRNSLaunch of Tender Offers for Bonds & Trading Updat
1st Jul 202412:01 pmRNSCredit Rating & Change of name of nomad
17th Jun 202410:18 amRNSResult of AGM
31st May 20243:03 pmRNSLogistics Sale Closing & Mandatory Bond Redemption
15th May 202410:14 amRNSNotice of AGM
7th May 202412:21 pmRNSBuyback of shares into treasury and TVR
26th Apr 20247:00 amRNSExchange Offer Final Settlement
22nd Apr 20244:35 pmRNSExchange Offer Final Results
11th Apr 20243:03 pmRNSIssue of Scrip Dividend Shares & Admission to AIM
10th Apr 202411:49 amRNSExchange Offer Early Exchange Deadline Results
3rd Apr 20247:00 amRNSSatisfaction of employee share awards and TVR
28th Mar 20244:25 pmRNSExchange Offer for Outstanding Notes 2025 and 2026
28th Mar 202412:00 pmRNSCorrection - Scrip Dividend Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.